CVLLY (CellaVision AB) Interest Expense: $-0.63 Mil (TTM As of Mar. 2026)

What is CellaVision AB Interest Expense?

CellaVision AB CVLLY +12.06% 69 Interest Expense is $-0.63 Mil as of Mar. 2026. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CellaVision AB's interest expense for the three months ended in Mar. 2026 was $ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.63 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CellaVision AB's Operating Income for the three months ended in Mar. 2026 was $ 3.06 Mil. CellaVision AB's Interest Expense for the three months ended in Mar. 2026 was $ -0.05 Mil. CellaVision AB's Interest Coverage for the quarter that ended in Mar. 2026 was 62.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CellaVision AB (OTCPK:CVLLY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CellaVision AB's Interest Expense for the three months ended in Mar. 2026 was $-0.05 Mil. Its Operating Income for the three months ended in Mar. 2026 was $3.06 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1.11 Mil.

CellaVision AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	3.059	/	-0.049
	=	62.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

CellaVision AB Interest Expense Historical Data

* Premium members only.

The historical data trend for CellaVision AB's Interest Expense can be seen below:

CellaVision AB Interest Expense Chart

CellaVision AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.21

-0.23

-0.32

-0.17

-0.10

CellaVision AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.52	-0.43	-0.04	-0.10	-0.05

69GF Score

CellaVision AB CVLLY

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

CellaVision AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.63 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.63 Mil mean?

CellaVision AB (CVLLY) has a Interest Expense of $-0.63 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on CellaVision AB and its competitors.

Is CellaVision AB's Interest Expense too high?

CellaVision AB's current Interest Expense is $-0.63 Mil. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does CellaVision AB's Interest Expense compare to ABT and SYK?

CellaVision AB's Interest Expense of $-0.63 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on CellaVision AB and its competitors. CellaVision AB's current Interest Expense is $-0.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is CellaVision AB stock overvalued right now?

Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current Interest Expense is $-0.63 Mil. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current Interest Expense is $-0.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellaVision AB (CVLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48. GuruFocus considers CellaVision AB to be Significantly Undervalued.

Key valuation signals for CVLLY:

Interest Expense: $-0.63 Mil
GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellaVision AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:DVYSR OSTO:BICO OSTO:PAX OSTO:CRAD B OSTO:SEDANA OSTO:EPIS B OSTO:SEZI OSTO:BACTI B OSTO:SCIB OSTO:OSSD ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges CLVSF:USA CEVI:Sweden 0MR5:UK C26:Germany

Address Mobilvagen 12, Lund, SWE, 22362

Website https://www.cellavision.com

CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.

69GF Score

Get the complete analysis for CVLLY

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.06

Price

$12.48

GF Value

View CVLLY Analysis

See Interest Expense data for all stocks →